The Impact of Dexamphetamine Treatment for Obesity on Executive Function: A Double-Blind Randomised Controlled Pilot Study
There was no discernible impact of amphetamine treatment for obesity on executive function. Our results suggest some variation related to sample size and/or practice effects. Thus, while treatment appears unlikely to render individuals susceptible to substance use disorders, parallels with ADHD might be overstated.
Authors
- Antoinette Poulton (ORCID: https://orcid.org/0000-0001-9291-6128)
- Alison Poulton (ORCID: https://orcid.org/0000-0002-5867-2403)
- Hazer Khalifa (ORCID: https://orcid.org/0000-0001-6965-0712)
- Emily Hibbert (ORCID: https://orcid.org/0000-0002-1151-2816)
- Natalie Gauci
Institutions
- The University of Sydney (AU)
- The University of Melbourne (AU)
- Nepean Hospital (AU)
Publication Details
- Journal
- Brain Sciences
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3390/brainsci14121274
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Australian Government